Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,361,978
Total 13F shares
2,921,778
Share change
-1,495,829
Total reported value
$2,436,675
Put/Call ratio
106%
Price per share
$0.83
Number of holders
24
Value change
-$1,654,962
Number of buys
8
Number of sells
19

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Dexcel Pharma Technologies Ltd.
3/4/5
10%+ Owner
class O/S missing
3,637,314
$5,128,613 02 Jun 2021
MORGAN STANLEY
13F
Company
2.8%
2,285,025
$3,039,000 30 Sep 2021
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.32%
254,871
$339,000 30 Sep 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.31%
251,171
$334,000 30 Sep 2021
13F
MEITAV INVESTMENT HOUSE LTD
13F
Company
0.3%
244,332
$325,000 30 Sep 2021
13F
Phoenix Financial Ltd.
13F
Company
0.3%
244,113
$325,000 30 Sep 2021
13F
GROUP ONE TRADING LLC
13F
Company
0.28%
222,553
$296,000 30 Sep 2021
13F
Walleye Capital LLC
13F
Company
0.27%
220,089
$293,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
0.15%
119,555
$159,000 30 Sep 2021
13F
SIMPLEX TRADING, LLC
13F
Company
0.09%
69,049
$129,000 30 Sep 2021
13F
Walleye Trading LLC
13F
Company
0.1%
81,000
$108,000 30 Sep 2021
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.07%
59,500
$79,000 30 Sep 2021
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
58,890
$78,000 30 Sep 2021
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
40,949
$54,000 30 Sep 2021
13F
DAVENPORT & Co LLC
13F
Company
0.04%
36,000
$48,000 30 Sep 2021
13F
IHT Wealth Management, LLC
13F
Company
0.04%
33,200
$44,000 30 Sep 2021
13F
CREDIT SUISSE AG/
13F
Company
0.04%
31,974
$43,000 30 Sep 2021
13F
WOLVERINE TRADING, LLC
13F
Company
0.04%
28,168
$39,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
24,945
$34,000 30 Sep 2021
13F
XTX Topco Ltd
13F
Company
0.03%
20,514
$27,000 30 Sep 2021
13F
Spire Wealth Management
13F
Company
0.02%
18,000
$24,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.02%
14,200
$19,000 30 Sep 2021
13F
Cutler Group LLC / CA
13F
Company
0.01%
11,267
$14,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
8,890
$12,000 30 Sep 2021
13F
Psagot Value Holdings Ltd.
13F
Company
0.01%
6,000
$8,000 30 Sep 2021
13F
Psagot Value Holdings Ltd. / (Israel)
13F
Company
0.01%
6,000
$8,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
5,847
$8,000 30 Sep 2021
13F
FEDERATED HERMES, INC.
13F
Company
0.01%
5,761
$8,000 30 Sep 2021
13F
Migdal Insurance & Financial Holdings Ltd.
13F
Company
0%
4,000
$5,000 30 Sep 2021
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
3,000
$4,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0%
2,194
$3,000 30 Sep 2021
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
1,100
$1,463 30 Sep 2021
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
1,000
$1,000 30 Sep 2021
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0%
800
$1,000 30 Sep 2021
13F
Ten Capital Wealth Advisors, LLC
13F
Company
0%
552
$1,000 30 Sep 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
500
$1,000 30 Sep 2021
13F

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2021

As of 31 Dec 2021, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,921,778 shares. The largest 10 holders included MORGAN STANLEY, GROUP ONE TRADING, L.P., Phoenix Holdings Ltd., Spire Wealth Management, BlackRock Inc., TWO SIGMA ADVISERS, LP, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
32
Q4 2021 holders
24
Holder diff
-8
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.